Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.
Type:
Grant
Filed:
November 17, 2021
Date of Patent:
November 28, 2023
Assignee:
Vymedic, LLC
Inventors:
Kenneth E. Phillips, Cynthia A. Winning
Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.
Type:
Grant
Filed:
September 25, 2019
Date of Patent:
January 18, 2022
Assignee:
Vymedic, LLC
Inventors:
Kenneth E. Phillips, Cynthia A. Winning
Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.
Type:
Grant
Filed:
January 29, 2018
Date of Patent:
November 19, 2019
Assignee:
Vymedic, LLC
Inventors:
Kenneth E. Phillips, Cynthia A. Winning
Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.
Type:
Grant
Filed:
April 8, 2015
Date of Patent:
March 6, 2018
Assignee:
Vymedic, LLC
Inventors:
Kenneth E. Phillips, Cynthia A. Winning
Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.
Type:
Grant
Filed:
October 30, 2009
Date of Patent:
May 19, 2015
Assignee:
Vymedic, LLC
Inventors:
Kenneth E. Phillips, Cynthia A. Winning
Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.
Type:
Application
Filed:
October 30, 2009
Publication date:
May 6, 2010
Applicant:
VYMEDIC, LLC
Inventors:
Kenneth E. Phillips, Cynthia A. Winning
© 2026 Justia
